The National Health Insurance (NHI) is to include more medicines for cancer, osteoporosis, chronic kidney diseases and other diseases, the National Health Insurance Administration (NHIA) said yesterday, adding that the initiative would take effect on Feb. 1 next year at the earliest.
As the number of people with high blood pressure, diabetes and obesity in the nation rises and the onset age of kidney diseases decreases, increasingly more people are on dialysis.
About 100,000 Taiwanese are on kidney dialysis — the highest rate of kidney dialysis patients per capita in the world — and the treatment could cost the NHI system up to NT$50 billion (US$1.53 billion) per year, the agency said, citing data from the Health Promotion Administration.
Photo: Chiu Chih-jou, Taipei Times
NHIA Director-General Shih Chung-liang (石崇良) yesterday said that NT$5.95 billion would be allocated to the NHI fund for reimbursement of drugs for cancer, osteoporosis, chronic renal diseases and other diseases, and it is expected to benefit more than 310,000 people.
A medicine to be included in the NHI benefit catalogue is sodium–glucose cotransporter-2 inhibitors, which could delay deterioration of kidney diseases and reduce the risk of heart failure in clinical trials, he said.
It would be reimbursable for patients with a glomerular filtration rate of 25 to 60, expected to prevent their conditions from worsening to the extent that dialysis is inevitable, Shih said.
However, people would not be eligible for reimbursement without signing up for an early-stage chronic kidney disease integrated care program or a care and health counseling project for patients with renal disease, he said.
The agency would require people to change their lifestyle and track their renal function to qualify, he said.
The reimbursement is projected to benefit 153,000 patients with renal diseases, while the listing of medicine for chronic systolic heart failure would benefit 16,000 people, Shih said, adding that the annual total expenditure would be up to NT$1.6 billion.
In terms of cancer drugs, immune checkpoint inhibitors, or immuno-oncology (IO) therapies, were added to the catalogue, including durvalumab and tremelimumab, which are applicable to patients with liver or bile duct cancer, Shih said, adding that it would benefit 1,938 people with an annual expense of about NT$1.28 billion.
The combination of durvalumab and tremelimumab is a dual IO therapy applicable to liver cancer based on international standards, he said.
For the first time, IO therapies are to be approved for bile duct cancer, which is highly malignant and has few therapy options. They are to be used in small cell lung cancer as well, he added.
Trastuzumab deruxtecan would also be reimbursable for patients with human epidermal growth factor receptor 2-positive breast cancer, which is expected to benefit 1,172 people by saving NT$1.46 million of medicine expenditure per capita a year, Shih said.
The annual NHI reimbursement for the therapy would total NT$1.59 billion, he said.
Bevacizumab, a targeted therapy drug for colorectal cancer, would be listed as a second-line therapy and benefit 842 people, with an annual NHI reimbursement of about NT$202 million, he said.
As Taiwan ages, medicines for osteoporosis would be part of primary prevention for people with high-risk factors, he said, adding that secondary prevention would be expanded to cover people with radius or humerus fractures.
The Ministry of Foreign Affairs (MOFA) yesterday said it is closely monitoring developments in Venezuela, and would continue to cooperate with democratic allies and work together for regional and global security, stability, and prosperity. The remarks came after the US on Saturday launched a series of airstrikes in Venezuela and kidnapped Venezuelan President Nicolas Maduro, who was later flown to New York along with his wife. The pair face US charges related to drug trafficking and alleged cooperation with gangs designated as terrorist organizations. Maduro has denied the allegations. The ministry said that it is closely monitoring the political and economic situation
UNRELENTING: China attempted cyberattacks on Taiwan’s critical infrastructure 2.63 million times per day last year, up from 1.23 million in 2023, the NSB said China’s cyberarmy has long engaged in cyberattacks against Taiwan’s critical infrastructure, employing diverse and evolving tactics, the National Security Bureau (NSB) said yesterday, adding that cyberattacks on critical energy infrastructure last year increased 10-fold compared with the previous year. The NSB yesterday released a report titled Analysis on China’s Cyber Threats to Taiwan’s Critical Infrastructure in 2025, outlining the number of cyberattacks, major tactics and hacker groups. Taiwan’s national intelligence community identified a large number of cybersecurity incidents last year, the bureau said in a statement. China’s cyberarmy last year launched an average of 2.63 million intrusion attempts per day targeting Taiwan’s critical
‘SLICING METHOD’: In the event of a blockade, the China Coast Guard would intercept Taiwanese ships while its navy would seek to deter foreign intervention China’s military drills around Taiwan this week signaled potential strategies to cut the nation off from energy supplies and foreign military assistance, a US think tank report said. The Chinese People’s Liberation Army (PLA) conducted what it called “Justice Mission 2025” exercises from Monday to Tuesday in five maritime zones and airspace around Taiwan, calling them a warning to “Taiwanese independence” forces. In a report released on Wednesday, the Institute for the Study of War said the exercises effectively simulated blocking shipping routes to major port cities, including Kaohsiung, Keelung and Hualien. Taiwan would be highly vulnerable under such a blockade, because it
UNDER WAY: The contract for advanced sensor systems would be fulfilled in Florida, and is expected to be completed by June 2031, the Pentagon said Lockheed Martin has been given a contract involving foreign military sales to Taiwan to meet what Washington calls “an urgent operational need” of Taiwan’s air force, the Pentagon said on Wednesday. The contract has a ceiling value of US$328.5 million, with US$157.3 million in foreign military sales funds obligated at the time of award, the Pentagon said in a statement. “This contract provides for the procurement and delivery of 55 Infrared Search and Track Legion Enhanced Sensor Pods, processors, pod containers and processor containers required to meet the urgent operational need of the Taiwan air force,” it said. The contract’s work would be
RSS